[go: up one dir, main page]

WO2014198913A3 - Nouvel isolat de piscirickettsia salmonis - Google Patents

Nouvel isolat de piscirickettsia salmonis Download PDF

Info

Publication number
WO2014198913A3
WO2014198913A3 PCT/EP2014/062409 EP2014062409W WO2014198913A3 WO 2014198913 A3 WO2014198913 A3 WO 2014198913A3 EP 2014062409 W EP2014062409 W EP 2014062409W WO 2014198913 A3 WO2014198913 A3 WO 2014198913A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel
piscirickettsia salmonis
piscirickettsia
isolate
salmonis isolate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2014/062409
Other languages
English (en)
Other versions
WO2014198913A2 (fr
Inventor
Henrik DUESUND
Julio MENDOZAS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cermaq Group AS
Original Assignee
Cermaq Group AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51211728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2014198913(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cermaq Group AS filed Critical Cermaq Group AS
Priority to GB1522295.3A priority Critical patent/GB2530210B/en
Priority to CA2915211A priority patent/CA2915211C/fr
Publication of WO2014198913A2 publication Critical patent/WO2014198913A2/fr
Publication of WO2014198913A3 publication Critical patent/WO2014198913A3/fr
Anticipated expiration legal-status Critical
Priority to NO20160051A priority patent/NO20160051A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A42—HEADWEAR
    • A42B—HATS; HEAD COVERINGS
    • A42B3/00—Helmets; Helmet covers ; Other protective head coverings
    • A42B3/04—Parts, details or accessories of helmets
    • A42B3/08—Chin straps or similar retention devices
    • A—HUMAN NECESSITIES
    • A42—HEADWEAR
    • A42B—HATS; HEAD COVERINGS
    • A42B3/00—Helmets; Helmet covers ; Other protective head coverings
    • A42B3/04—Parts, details or accessories of helmets
    • A42B3/08—Chin straps or similar retention devices
    • A42B3/085—Occipital retention systems
    • A—HUMAN NECESSITIES
    • A42—HEADWEAR
    • A42B—HATS; HEAD COVERINGS
    • A42B3/00—Helmets; Helmet covers ; Other protective head coverings
    • A42B3/04—Parts, details or accessories of helmets
    • A42B3/10—Linings
    • A42B3/14—Suspension devices
    • A42B3/145—Size adjustment devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Meat, Egg Or Seafood Products (AREA)

Abstract

La présente invention concerne une nouvelle souche de Piscirickettsia salmonis utile comme agent thérapeutique, plus particulièrement dans des vaccins. La présente invention concerne en outre un nouveau milieu de croissance utile pour la culture de Piscirickettsia spp..
PCT/EP2014/062409 2013-06-14 2014-06-13 Nouvel isolat de piscirickettsia salmonis Ceased WO2014198913A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB1522295.3A GB2530210B (en) 2013-06-14 2014-06-13 Novel piscirickettsia salmonis isolate
CA2915211A CA2915211C (fr) 2013-06-14 2014-06-13 Nouvel isolat de piscirickettsia salmonis
NO20160051A NO20160051A1 (en) 2013-06-14 2016-01-12 Novel piscirickettsia salmonis isolate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361834885P 2013-06-14 2013-06-14
US61/834,885 2013-06-14

Publications (2)

Publication Number Publication Date
WO2014198913A2 WO2014198913A2 (fr) 2014-12-18
WO2014198913A3 true WO2014198913A3 (fr) 2015-02-26

Family

ID=51211728

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/062409 Ceased WO2014198913A2 (fr) 2013-06-14 2014-06-13 Nouvel isolat de piscirickettsia salmonis

Country Status (5)

Country Link
CA (1) CA2915211C (fr)
CL (1) CL2015003616A1 (fr)
GB (1) GB2530210B (fr)
NO (1) NO20160051A1 (fr)
WO (1) WO2014198913A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3249041A1 (fr) * 2014-11-24 2017-11-29 Pontificia Universidad Católica De Valparaíso Milieu de culture permettant la croissance de la bactérie piscirickettsia salmonis
GB201509004D0 (en) * 2015-05-26 2015-07-08 Pharmaq As Attenuated bacterium

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008002152A2 (fr) * 2006-06-29 2008-01-03 Pharmaq As Procédé de culture de bactéries du genre piscirickettsia
US20090162391A1 (en) * 2007-12-19 2009-06-25 Schering-Plough Animal Health Corporation Vaccine antigens from piscirickettsia salmonis
WO2013084169A2 (fr) * 2011-12-07 2013-06-13 Yanez Carcamo Alejandro Javier Nouveau substrat de bouillon et substrats solides exempts de sang pour la culture du pathogène de poisson piscirickettsia salmonis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008002152A2 (fr) * 2006-06-29 2008-01-03 Pharmaq As Procédé de culture de bactéries du genre piscirickettsia
US20090162391A1 (en) * 2007-12-19 2009-06-25 Schering-Plough Animal Health Corporation Vaccine antigens from piscirickettsia salmonis
WO2013084169A2 (fr) * 2011-12-07 2013-06-13 Yanez Carcamo Alejandro Javier Nouveau substrat de bouillon et substrats solides exempts de sang pour la culture du pathogène de poisson piscirickettsia salmonis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KUZYK M A ET AL: "An efficacious recombinant subunit vaccine against the salmonid rickettsial pathogen Piscirickettsia salmonis", VACCINE, ELSEVIER LTD, GB, vol. 19, no. 17-19, 21 March 2001 (2001-03-21), pages 2337 - 2344, XP027349941, ISSN: 0264-410X, [retrieved on 20010321] *
M. J. MAUEL ET AL: "Culture of Piscirickettsia salmonis on enriched blood agar", JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, vol. 20, no. 2, 1 March 2008 (2008-03-01), pages 213 - 214, XP055144865, ISSN: 1040-6387, DOI: 10.1177/104063870802000211 *

Also Published As

Publication number Publication date
GB2530210B (en) 2017-12-27
GB2530210A (en) 2016-03-16
NO20160051A1 (en) 2016-01-12
CA2915211A1 (fr) 2014-12-18
CL2015003616A1 (es) 2016-09-23
WO2014198913A2 (fr) 2014-12-18
CA2915211C (fr) 2022-08-23
GB201522295D0 (en) 2016-02-03

Similar Documents

Publication Publication Date Title
EP3098300A4 (fr) Composition de milieu de culture
WO2012100224A3 (fr) Préparation de réseaux métal- triazolate
EP3101136A4 (fr) Souche de bacillus sp. ayant une productivité en farine de soja fermentée améliorée, et procédé de préparation de farine de soja fermentée l'utilisant
HK1198689A1 (en) Antibody formulations and methods
WO2012162534A3 (fr) Peptidoglycanes synthétiques se liant à l'acide hyaluronique, préparation et procédés d'utilisation
WO2013177133A3 (fr) Génération de cellules ips humaines par un arn de synthèse auto-réplicatif
TN2013000378A1 (en) Anti - sclerostin antibody crystals and formulations thereof
EP3022383A4 (fr) Modules de compensation de pression pour des outils de carottage, outils de carottage comprenant des modules de compensation de pression, et procédés s'y rapportant
ZA201404199B (en) Compositions, comprising improved il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same.
EP3098299A4 (fr) Procédé de production d'une composition pour milieu de culture
EP3140305A4 (fr) Nouvelles compositions, leurs utilisations et leurs procédés de préparation
EP3125828A4 (fr) Valvule cardiaque à haute durabilité
EP3118307A4 (fr) Activateur de cellules souches mésenchymateuses, cellules mésenchymateuses activées, et leur procédé de production
EP3572405B8 (fr) Benzoimidazol-1,2-yl amides en tant qu'activateurs du canal kv7
EP3184627A4 (fr) Milieu de culture pour cellules souches mésenchymateuses
ZA202000574B (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
EP3124602A4 (fr) Milieu de culture pour cellules souches pluripotentes
WO2014091167A3 (fr) Composes cyclopropylboroniques, leur procede de preparation et leur utilisation
WO2012125946A3 (fr) Dispositifs de curiethérapie gonflables à plusieurs segments, systèmes et procédés d'utilisation correspondants
EP3075393A4 (fr) Composition adjuvante, composition vaccinale la contenant et procédé de production associé
EP3153574A4 (fr) Microorganisme pour la production d'o-acétyl-homosérine et procédé de production d'o-acétyl-homosérine l'utilisant
WO2013123046A3 (fr) Matériaux tampons de cathode et dispositifs et procédés associés
EP3128003A4 (fr) Milieu pour l'utilisation de cellules souches
EP3252146A4 (fr) Composition de milieu pour la culture de cellules souches
WO2012021678A3 (fr) Bactéries isolées, procédés d'utilisation et procédés d'isolement

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14741530

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2915211

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 1522295

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20140613

122 Ep: pct application non-entry in european phase

Ref document number: 14741530

Country of ref document: EP

Kind code of ref document: A2